Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88347233 | 8834723 | 3 | F | 20160725 | 20121010 | 20160727 | EXP | SA-ROCHE-1139807 | ROCHE | , ALENAZI A AND ALJASSER H BIOLOGIC AGENTS THERAPY FOR SAUDI CHILDREN WITH RHEUMATIC DISEASES: INDICATIONS AND SAFETY. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 2016 JUN 01;19 (6):600-605. | 0.00 | C | Y | 0.00000 | 20160727 | OT | SA | SA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88347233 | 8834723 | 1 | PS | Rituximab | RITUXIMAB | 1 | Unknown | U | 103705 | ||||||||||
| 88347233 | 8834723 | 2 | SS | Rituximab | RITUXIMAB | 1 | U | 103705 | |||||||||||
| 88347233 | 8834723 | 3 | SS | Rituximab | RITUXIMAB | 1 | U | 103705 | |||||||||||
| 88347233 | 8834723 | 4 | SS | Rituximab | RITUXIMAB | 1 | U | 103705 | |||||||||||
| 88347233 | 8834723 | 5 | SS | Tocilizumab | TOCILIZUMAB | 1 | Unknown | 125276 | |||||||||||
| 88347233 | 8834723 | 6 | SS | Tocilizumab | TOCILIZUMAB | 1 | 125276 | ||||||||||||
| 88347233 | 8834723 | 7 | SS | Tocilizumab | TOCILIZUMAB | 1 | 125276 | ||||||||||||
| 88347233 | 8834723 | 8 | SS | Tocilizumab | TOCILIZUMAB | 1 | 125276 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 88347233 | 8834723 | 1 | Juvenile idiopathic arthritis |
| 88347233 | 8834723 | 2 | Systemic lupus erythematosus |
| 88347233 | 8834723 | 3 | Vasculitis |
| 88347233 | 8834723 | 4 | Autoinflammatory disease |
| 88347233 | 8834723 | 5 | Juvenile idiopathic arthritis |
| 88347233 | 8834723 | 6 | Systemic lupus erythematosus |
| 88347233 | 8834723 | 7 | Vasculitis |
| 88347233 | 8834723 | 8 | Autoinflammatory disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 88347233 | 8834723 | HO |
| 88347233 | 8834723 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 88347233 | 8834723 | Autoantibody positive | |
| 88347233 | 8834723 | Fungal infection | |
| 88347233 | 8834723 | Histiocytosis haematophagic | |
| 88347233 | 8834723 | Infection | |
| 88347233 | 8834723 | Infusion related reaction | |
| 88347233 | 8834723 | Leukopenia | |
| 88347233 | 8834723 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |